Fertility Preservation Network Welcomes Augusta Georgia Area Facility
Program greatly extends access to Fertility Preservation services.
St. Paul, MN, September 07, 2014 --(PR.com)-- ReproTech, Ltd., the leading cryobank specializing in long-term storage of human reproductive tissue (sperm, eggs, embryos and ovarian and testicular tissue), has reached an agreement with Georgia Regents Health Care.
Georgia Regents Reproductive Medicine and Infertility Associates, located in Augusta, Georgia joins the more than 100 facilities included in ReproTech’s Fertility Preservation Network. The growing network of fertility centers in 36 states through out the U.S., provides much needed Fertility Preservation services to cancer patients prior to the initiation of oncology treatments.
“This is a very valuable service for cancer patients,” says Brent Hazelrigg, President and CEO of ReproTech, Ltd. “With the growing success of cancer therapies and tremendous advancements in fertility treatment, cancer survivors today have an excellent chance of having families provided they are given the opportunity to cryopreserve reproductive tissue prior to their oncology treatment.”
“Georgia Regents Health Care is pleased to be a part of ReproTech’s Fertility Preservation Network. We look forward to our practice enabling patients faced with oncology treatments to have options for fertility preservation, including freezing their specimens for future family building,” says Dr. Larisa Gavrilova-Jordan, Director of IVF Service, Georgia Regents University.
According to the American Cancer Society, 140,000 men and women of childbearing age are newly diagnosed with cancer each year. There often is a small window of time for them to preserve their fertility; therefore, access to cryopreservation services is extremely important. Both the American Society of Clinical Oncology (ASCO) and American Society for Reproductive Medicine (ASRM) recommend the education of oncology patients about the options available to preserve their fertility. In 2013 the American Medical Association (AMA) adopted a policy encouraging coverage by all insurance providers of fertility preservation therapies for patients requiring cancer treatments that result in infertility.
ReproTech, Ltd. has organized the Fertility Preservation Network to educate oncology professionals and caretakers, as well as provide the much needed cryopreservation services. The Network now includes members in 36 states and the Caribbean. Additionally, the work of LIVESTRONG has advanced the awareness of the need for Fertility Preservation among the oncology community.
About ReproTech, Ltd.
ReproTech, Ltd. was founded in 1990 for the purpose of providing long-term cryostorage services and now operates regional cryostorage centers in Florida, Minnesota, Nevada and Texas. More information on ReproTech, Ltd. is available at www.reprotech.com or 888-489-8944. Information specific to the Fertility Preservation Network and its members can be found at www.fertilitypreservation.com.
About Georgia Regents Reproductive Medicine and Infertility Associates
Georgia Regents Reproductive Medicine and Infertility Associates provides comprehensive healthcare to men and women with problems that center on infertility, reproductive disorders and genetics in a courteous and empathetic manner. The practice continues ongoing research in human infertility and all of the practice fertility specialists are board certified in Reproductive Endocrinology and Infertility and are also certified in Obstetrics and Gynecology.
Georgia Regents Reproductive Medicine and Infertility Associates, located in Augusta, Georgia joins the more than 100 facilities included in ReproTech’s Fertility Preservation Network. The growing network of fertility centers in 36 states through out the U.S., provides much needed Fertility Preservation services to cancer patients prior to the initiation of oncology treatments.
“This is a very valuable service for cancer patients,” says Brent Hazelrigg, President and CEO of ReproTech, Ltd. “With the growing success of cancer therapies and tremendous advancements in fertility treatment, cancer survivors today have an excellent chance of having families provided they are given the opportunity to cryopreserve reproductive tissue prior to their oncology treatment.”
“Georgia Regents Health Care is pleased to be a part of ReproTech’s Fertility Preservation Network. We look forward to our practice enabling patients faced with oncology treatments to have options for fertility preservation, including freezing their specimens for future family building,” says Dr. Larisa Gavrilova-Jordan, Director of IVF Service, Georgia Regents University.
According to the American Cancer Society, 140,000 men and women of childbearing age are newly diagnosed with cancer each year. There often is a small window of time for them to preserve their fertility; therefore, access to cryopreservation services is extremely important. Both the American Society of Clinical Oncology (ASCO) and American Society for Reproductive Medicine (ASRM) recommend the education of oncology patients about the options available to preserve their fertility. In 2013 the American Medical Association (AMA) adopted a policy encouraging coverage by all insurance providers of fertility preservation therapies for patients requiring cancer treatments that result in infertility.
ReproTech, Ltd. has organized the Fertility Preservation Network to educate oncology professionals and caretakers, as well as provide the much needed cryopreservation services. The Network now includes members in 36 states and the Caribbean. Additionally, the work of LIVESTRONG has advanced the awareness of the need for Fertility Preservation among the oncology community.
About ReproTech, Ltd.
ReproTech, Ltd. was founded in 1990 for the purpose of providing long-term cryostorage services and now operates regional cryostorage centers in Florida, Minnesota, Nevada and Texas. More information on ReproTech, Ltd. is available at www.reprotech.com or 888-489-8944. Information specific to the Fertility Preservation Network and its members can be found at www.fertilitypreservation.com.
About Georgia Regents Reproductive Medicine and Infertility Associates
Georgia Regents Reproductive Medicine and Infertility Associates provides comprehensive healthcare to men and women with problems that center on infertility, reproductive disorders and genetics in a courteous and empathetic manner. The practice continues ongoing research in human infertility and all of the practice fertility specialists are board certified in Reproductive Endocrinology and Infertility and are also certified in Obstetrics and Gynecology.
Contact
ReproTech, Ltd.
Courtney Dennewitz
888-489-8944
www.reprotech.com
Courtney Dennewitz
888-489-8944
www.reprotech.com
Contact
Categories